Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Developing and evaluating rare disease educational materials co-created by expert clinicians and patients: the paradigm of congenital hypogonadotropic hypogonadism

Research output: Contribution to journalJournal articleResearchpeer-review

  1. An ontological foundation for ocular phenotypes and rare eye diseases

    Research output: Contribution to journalLetterResearchpeer-review

  2. Research activity and capability in the European reference network MetabERN

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The complete European guidelines on phenylketonuria: diagnosis and treatment

    Research output: Contribution to journalReviewResearchpeer-review

  1. Increases in bioactive IGF do not parallel increases in total IGF-I during growth hormone treatment of children born SGA

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Measurement of peripheral arterial tonometry in patients with diabetic foot ulcers during courses of hyperbaric oxygen treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A Polygenic Risk Score Suggests Shared Genetic Architecture of Voice Break With Early Markers of Pubertal Onset in Boys

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The External Genitalia Score (EGS): A European multicenter validation study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Corin Badiu
  • Marco Bonomi
  • Ivan Borshchevsky
  • Martine Cools
  • Margarita Craen
  • Cristina Ghervan
  • Michael Hauschild
  • Eli Hershkovitz
  • Erik Hrabovszky
  • Anders Juul
  • Soo-Hyun Kim
  • Phillip Kumanov
  • Beatriz Lecumberri
  • Manuel C Lemos
  • Vassos Neocleous
  • Marek Niedziela
  • Sandra Pekic Djurdjevic
  • Luca Persani
  • Franziska Phan-Hug
  • Duarte Pignatelli
  • Nelly Pitteloud
  • Vera Popovic
  • Richard Quinton
  • Nicos Skordis
  • Neil Smith
  • Magdalena Avbelj Stefanija
  • Cheng Xu
  • Jacques Young
  • Andrew A Dwyer
  • COST Action BM1105
View graph of relations

BACKGROUND: Patients with rare diseases face health disparities and are often challenged to find accurate information about their condition. We aimed to use the best available evidence and community partnerships to produce patient education materials for congenital hypogonadotropic hypogonadism (CHH) and the olfacto-genital (Kallmann) syndrome (i.e., CHH and defective sense of smell), and to evaluate end-user acceptability. Expert clinicians, researchers and patients co-created the materials in a multi-step process. Six validated algorithms were used to assess reading level of the final product. Comprehensibility and actionability were measured using the Patient Education Materials Assessment Tool via web-based data collection. Descriptive statistics were employed to summarize data and thematic analysis for analyzing open-ended responses. Subsequently, translation and cultural adaption were conducted by clinicians and patients who are native speakers.

RESULTS: Co-created patient education materials reached the target 6(th) grade reading level according to 2/6 (33%) algorithms (range: grade 5.9-9.7). The online survey received 164 hits in 2 months and 63/159 (40%) of eligible patients completed the evaluation. Patients ranged in age from 18 to 66 years (median 36, mean 39 ± 11) and 52/63 (83%), had adequate health literacy. Patients scored understandability at 94.2% and actionability at 90.5%. The patient education materials were culturally adapted and translated into 20 languages (available in Additional file 1).

CONCLUSIONS: Partnering with patients enabled us to create patient education materials that met patient- identified needs as evidenced by high end-user acceptability, understandability and actionability. The web-based evaluation was effective for reaching dispersed rare disease patients. Combining dissemination via traditional healthcare professional platforms as well as patient-centric sites can facilitate broad uptake of culturally adapted translations. This process may serve as a roadmap for creating patient education materials for other rare diseases.

Original languageEnglish
JournalOrphanet Journal of Rare Diseases
Volume12
Issue number1
Pages (from-to)57
ISSN1750-1172
DOIs
Publication statusPublished - 20 Mar 2017

    Research areas

  • Journal Article

ID: 50151249